TY  - JOUR

T1  - A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis.

JO  - Expert Rev Pharmacoecon Outcomes Res

PY  - 2014/01/09

AU  - Bansback N

AU  - Brennan A

AU  - Anis AH

ED  - 

DO  - DOI: 10.1586/14737167.5.5.519

VL  - 5

IS  - 5

SP  - 519

EP  - 529

Y2  - 2025/11/01

ER  -